Preclinical analysis of gnomAD and ClinVar databases on ADPLD variant frequencies
This is a preclinical analysis of genetic databases, not a clinical trial or observational study. The scope was to analyze gnomAD and ClinVar databases for predicted pathogenic variants in ADPLD genes, which are associated with autosomal dominant polycystic liver disease and kidney cysts. The authors synthesized population frequencies of these predicted variants.
Using a gnomAD v.2.1.1 strategy, the frequency of predicted pathogenic variants was one in 95 people. Using ClinVar assessments of gnomAD v.4.1 variants, the frequency was one in 151 people. Frequencies were higher in specific populations: one in 100 in the admixed American population, one in 107 in the Finnish population, and one in 130 in the African/African American population, all with p <0.0001 compared with Europeans. The frequency in the European population was one in 197.
The authors note that these are frequencies of predicted pathogenic variants and may not reflect actual disease prevalence due to incomplete penetrance and variable expressivity. Limitations were not reported. Practice relevance was not reported. The findings should be interpreted with caution, as this is a preclinical genetic database analysis.